Credit Suisse’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $418K | Buy |
|
|||||
|
2023
Q4 | $244K | Sell |
|
|||||
|
2023
Q3 | $270K | Sell |
|
|||||
|
2023
Q2 | $594K | Buy |
|
|||||
|
2023
Q1 | $523K | Buy |
|
|||||
|
2022
Q4 | $644K | Buy |
|
|||||
|
2022
Q3 | $889K | Buy |
|
|||||
|
2022
Q2 | $929K | Buy |
|
|||||
|
2022
Q1 | $615K | Buy |
|
|||||
|
2021
Q4 | $965K | Sell |
|
|||||
|
2021
Q3 | $2.01M | Buy |
|
|||||
|
2021
Q2 | $1.93M | Buy |
|
|||||
|
2021
Q1 | $2.2M | Sell |
|
|||||
|
2020
Q4 | $3.34M | Buy |
|
|||||
|
2020
Q3 | $4.39M | Sell |
|
|||||
|
2020
Q2 | $5.21M | Buy |
|
|||||
|
2020
Q1 | $1.43M | Sell |
|
|||||
|
2019
Q4 | $3.37M | Buy |
|
|||||
|
2019
Q3 | $525K | Buy |
|
|||||
|
2019
Q2 | $374K | Buy |
|